Key Regulatory Approval Details

Fischer Medical Ventures announced that its associate company, Nanomedic Technologies Ltd. (Lod, Israel), received regulatory clearance from India's Central Licensing Authority (CDSCO) to import and distribute the Spincare Portable Wound Care System. The approval was issued under Form MD-27 of the Medical Devices Rules, 2017, with Permission No. IMP/MD/2026/000455. The device is classified as a Class C medical device.

Product Specifications

The Spincare system is a portable, hand-held device that applies a breathable, transparent nanofiber film directly onto wounds at the point of care. It eliminates the need for traditional dressings in many clinical scenarios and carries a five-year shelf life. The device is indicated for use across:

  • Partial and full thickness wounds
  • Superficial and partial thickness burns
  • Donor site wounds
  • Surgical incisions and post-suture sites
  • Skin tears, dermatological lesions, and chronic ulcers

The system is designed for use by healthcare professionals in clinical environments.

Market Opportunity and Distribution Rights

Fischer Medical Ventures holds exclusive rights to distribute the Spincare system across India and Southeast Asia. India's wound care market is valued at approximately USD 380 million in 2026 and projected to reach USD 1.8 billion by 2033, growing at a CAGR of ~6.4% (Source: IMARC Group, India Wound Care Market Report, 2026). Southeast Asia's advanced wound care segment is projected to reach USD 354 million by 2030 (CAGR ~6.1%) (Source: Grand View Research, South East Asia Advanced Wound Care Market Report, 2030), with key markets including Indonesia, Malaysia, and Singapore.

Regulatory Status Updates

Nanomedic Technologies Ltd. has submitted its application for U.S. Food and Drug Administration (FDA) approval for Spincare. The approval process is currently underway, and the company expects to receive FDA clearance soon.

Management Commentary

Mr. Ravindran Govindan, Chairman & Managing Director of Fischer Medical Ventures Limited, stated: "Receiving CDSCO clearance for Spincare is a transformative moment for Fischer Medical Ventures. This approval opens the door to deploying a genuinely differentiated wound care technology across Indian hospitals and burn centers. We see substantial whitespace in this market and are moving quickly to establish our commercial footprint."